BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36913708)

  • 1. Effectiveness of proton beam therapy for liver oligometastatic recurrence in patients with postoperative esophagus cancer.
    Yamaguchi H; Kato T; Honda M; Hamada K; Seto I; Tominaga T; Takagawa Y; Takayama K; Suzuki M; Kikuchi Y; Teranishi Y; Murakami M
    J Radiat Res; 2023 May; 64(3):582-589. PubMed ID: 36913708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in esophagogastric cancer patients.
    Yamaguchi H; Fukumitsu N; Numajiri H; Ogino H; Katoh N; Okimoto T; Suzuki M; Sakurai H
    J Radiat Res; 2023 Nov; 64(6):926-932. PubMed ID: 37697668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in breast cancer patients.
    Yamaguchi H; Fukumitsu N; Numajiri H; Ogino H; Okimoto T; Ogino T; Suzuki M; Murayama S
    J Radiat Res; 2024 Mar; 65(2):231-237. PubMed ID: 38321606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer.
    Yamaguchi H; Kato T; Honda M; Hamada K; Todate Y; Ishikawa Y; Seto I; Tominaga T; Machida M; Takagawa Y; Takayama K; Suzuki M; Kikuchi Y; Teranishi Y; Murakami M; Konno S
    Strahlenther Onkol; 2023 Mar; 199(3):304-312. PubMed ID: 36446925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Beam Therapy for Lung Oligometastatic Recurrence in Patients With Esophageal Cancer.
    Yamaguchi H; Kato T; Honda M; Hamada K; Ishikawa Y; Seto I; Takagawa Y; Suzuki M; Kikuchi Y; Murakami M
    Cureus; 2023 Dec; 15(12):e50343. PubMed ID: 38205500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.
    Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Ishikawa Y; Azami Y; Kato T; Tsukiyama I; Kikuchi Y; Hareyama M; Murakami M; Fuwa N; Hata M; Inoue T
    Radiat Oncol; 2014 Jan; 9():26. PubMed ID: 24422711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective Study of Proton Beam Reirradiation for Esophageal Cancer.
    Fernandes A; Berman AT; Mick R; Both S; Lelionis K; Lukens JN; Ben-Josef E; Metz JM; Plastaras JP
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):483-487. PubMed ID: 26847847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of proton beam therapy for liver metastatic recurrence in gastric cancer patients.
    Yamaguchi H; Honda M; Hamada K; Kobayashi H; Todate Y; Seto I; Takayama K; Suzuki M; Wada H; Kikuchi Y; Murakami M
    Jpn J Clin Oncol; 2020 Aug; 50(8):903-908. PubMed ID: 32363379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton beam therapy for liver metastases from gastric cancer.
    Fukumitsu N; Okumura T; Takizawa D; Numajiri H; Ohnishi K; Mizumoto M; Aihara T; Ishikawa H; Tsuboi K; Sakurai H
    J Radiat Res; 2017 May; 58(3):357-362. PubMed ID: 27974509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Impact of Proton Beam Therapy for Postoperative Lymph Node Oligorecurrence of Esophageal Cancer.
    Hiroshima Y; Ishikawa H; Sumiya T; Murakami M; Nakamura M; Ishida T; Ogawa K; Hisakura K; Mizumoto M; Oda T; Okumura T; Sakurai H
    In Vivo; 2023; 37(3):1253-1259. PubMed ID: 37103111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.
    McAvoy S; Ciura K; Wei C; Rineer J; Liao Z; Chang JY; Palmer MB; Cox JD; Komaki R; Gomez DR
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):819-27. PubMed ID: 25220718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival after definitive proton beam therapy for oligorecurrent esophageal squamous cell carcinoma: a case report.
    Ishikawa Y; Suzuki M; Yamaguchi H; Seto I; Machida M; Takagawa Y; Jingu K; Kikuchi Y; Murakami M
    J Med Case Rep; 2022 Feb; 16(1):68. PubMed ID: 35152904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.
    Kim TH; Koh YH; Kim BH; Kim MJ; Lee JH; Park B; Park JW
    J Hepatol; 2021 Mar; 74(3):603-612. PubMed ID: 33031846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Endoscopic Evaluation of Acute Radiation Esophagitis during Chemoradiotherapy with Proton Beam Therapy Boost for Esophageal Cancer.
    Hasatani K; Tamamura H; Yamamoto K; Aoyagi H; Miyanaga T; Kaizaki Y; Sawada T
    Digestion; 2020; 101(4):366-374. PubMed ID: 31067539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer.
    McAvoy SA; Ciura KT; Rineer JM; Allen PK; Liao Z; Chang JY; Palmer MB; Cox JD; Komaki R; Gomez DR
    Radiother Oncol; 2013 Oct; 109(1):38-44. PubMed ID: 24016675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of proton beam therapy in central neurocytoma: A single-institution experience.
    Kang KH; Schapira E; Niemierko A; Martinez-Lage M; Bussière MR; Yock TI; Loeffler JS; Butler WE; Carter BS; Shih HA
    Pract Radiat Oncol; 2018; 8(5):e305-e311. PubMed ID: 29706302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis.
    Thorpe CS; Niska JR; Girardo ME; Kosiorek HE; McGee LA; Hartsell WF; Larson GL; Tsai HK; Rossi CJ; Rosen LR; Vargas CE
    Breast J; 2019 Nov; 25(6):1160-1170. PubMed ID: 31338974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage I non--small-cell lung cancer.
    Kanemoto A; Okumura T; Ishikawa H; Mizumoto M; Oshiro Y; Kurishima K; Homma S; Hashimoto T; Ohkawa A; Numajiri H; Ohno T; Moritake T; Tsuboi K; Sakae T; Sakurai H
    Clin Lung Cancer; 2014 Mar; 15(2):e7-12. PubMed ID: 24365049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose escalation study of proton beam therapy with concurrent chemotherapy for stage III non-small cell lung cancer.
    Harada H; Fuji H; Ono A; Kenmotsu H; Naito T; Yamashita H; Asakura H; Nishimura T; Takahashi T; Murayama S
    Cancer Sci; 2016 Jul; 107(7):1018-21. PubMed ID: 27110950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation.
    Choi JI; Khan AJ; Powell SN; McCormick B; Lozano AJ; Del Rosario G; Mamary J; Liu H; Fox P; Gillespie E; Braunstein LZ; Mah D; Cahlon O
    Radiother Oncol; 2021 Dec; 165():142-151. PubMed ID: 34688807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.